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SBRC-Nottingham: Sustainable Routes to Platform Chemicals from C1 Wastes
Gases
SBRC-Nottingham (www.sbrc-nottingham.ac.uk) was one of the first three UK
university-based Synthetic Biology Research Centres (SBRCs) to be funded by the
BBSRC and EPSRC as part of the recommendations made in the UKs Synthetic Biology
Roadmap. It was established in 2014 and builds on the pioneering work of the Clostridia
Research Group (CRG) who have previously developed a range of gene tools for the
modification of clostridial genomes [1-9].
Background to the CRG
Established in 2004, the CRG conducts research on biofuels [10-13], C. difficile infection
and control [14-17], understanding the food pathogen C. botulinum [18-21] as well as
developing therapeutic strategies for treating solid tumours [22-25]. The majority of this
work has focussed on clostridia but the establishment of the SBRC-Nottingham has
opened up the opportunity to a broader spectrum of bacteria and to now include
aerobes, specifically Cupriavidus necator.
CRG Roadmap Technologies
The CRG have developed a series of technologies which when sequentially applied, have
allowed the modification of new clostridial hosts. Several of the components of this
‘roadmap to gene system development’ are subject to patent protection: Synthetic
Operon Construction in Clostridia Allele Coupled Exchange (ACE, WO 2009/101400); A
negative / counter selection marker for use in clostridia: CodA selectable marker
(WO2010/084349); Transposon delivery system for clostridia (vector) TraDis Transposon
system (WO2013/144653); Orthogonal bacterial expression system (WO2013/144647);
ClosTron (www.clostron.com) technology (WO/2007/148091). These technologies, along
with the pMTL80000 modular vector series [1], are used to facilitate gene transfer and
gene knock-out/knock-in and to generate bespoke chassis carrying genome inserted
synthetic pathways and application specific modules.
SBRC Focus
Unlike many of the other UK SBRC’s the scope of the SBRC-Nottingham is highly directed
and focuses on the conversion of waste C1 gases through bacterial fermentation to
industrially useful hydrocarbon-based chemicals. The particular focus are those with
multiple bonds (alkenes) such as s-hydroxyproprionic acid, ethylene, propylene,
isobutene, butadiene and isoprene. The molecules were chosen because of their
industrial relevance, because they are ‘stepping off’ points for the production of more
complex compounds using sustainable chemistry and because they are volatile, hence
more easily recovered from the fermentation system which in turn helps prevent product
levels accumulating to levels toxic to the bacteria.
The long-term aim of the SBRC-Nottingham is to break our reliance on fossil fuels as
the source of the chemicals we use in our everyday lives and to make these chemicals
sustainably using waste C1 whilst at the same time reducing C1 gas evolution to the
atmosphere, hence reducing greenhouse gas emissions.
The SBRC-Nottingham is applying learning from the CRG to the Gram-negative
bacterium Cupriavidis necator (formerly known as Ralstonia eutropha or Alcaligenes
eutropha). This industrially relevant, facultatively chemolithoautotrophic bacterium is
able to grow with organic substrates or H2 and CO2 under aerobic conditions. Under
nutrient limitation, C. necator directs the majority of its reduced carbon flux into the
synthesis of poly[(R)-3-hydroxybutyrate] (PHB), a biopolymer stored in intracellular
granules. When cultivated with H2 and CO2, C. necator forms up to 61 g/liter of PHB in
48 h, representing about 70% of total cell weight [26]. Mutants defective in PHB
production secrete large amounts of pyruvate into the growth medium when cultured
chemolithoautotrophically, suggesting that these mutants maintain a comparable carbon
flux in the presence or absence of PHB biosynthesis [27, 28].
Biosynthesis of PHB under nutrient-limiting conditions in C. necator has been
industrially exploited in the production of biodegradable plastic for more than a decade
(e.g., by ICI/Zeneca, Monsanto, and Metabolix). Only recently has C. necator been
recognized as a candidate for biofuel production from CO2, potentially producing carbon-
neutral biofuels from nonphotosynthetic sources. Li and co-workers engineered a C.
necator strain for electromicrobial conversion of CO2 to C4 and C5 alcohols [29]. In their
system, electricity powered the electrochemical reduction of CO2 at a cathode to produce
formate, which was then converted to isobutanol and 3-methyl-1-butanol by an
engineered C. necator strain. With such a capacity to synthesise and store fixed carbon
from CO2, C. necator offers the promise of a chassis which through synthetic biology
approaches will be able to synthesise and store other, industrially important platform
chemicals.
Inter-disciplinarity
Synthetic biology is inherently multidisciplinary and the Centre’s academic leadership
team membership is drawn from faculties and schools across the university including
Chemistry, Life Sciences, Mathematics, Computer Science, Engineering, Social Sciences,
Pharmacy and Biosciences. To create a coherent research community the SBRC -
Nottingham has been provided with a dedicated floor in the University’s flagship
Biomolecular Sciences research building on the University Park campus. This is a £40
million multidisciplinary research facility which also houses other multi-disciplinary
teams. Researchers within the SBRC-Nottingham are co-located, in particular ‘lab-based’
scientists and mathematical modellers work in multidisciplinary teams. The SBRC-
Nottingham is located within the science and engineering hub of the university with
mechanisms in place for researchers based on other Campuses to spend dedicated time
within the team. The SBRC-Nottingham positions Responsible Research and Innovation
central to its activities with social scientists physically based within the SBRC to
maximise interaction with synthetic scientists. There is a strong Outreach ethos with
many links between the SBRC-Nottingham, local schools, Café Scientifique, Pub PhD, the
media and other UK SBRCs. Many of these activities are undertaken in partnership with
C1net (www.c1net.co.uk), a BBSRC Network in Industrial Biotechnology and Bioenergy
(NIBB) coordinated from Nottingham.
Equipment and facilities
The SBRC-Nottingham has a wealth of dedicated new equipment, including flow
cytometry, lab-scale fermentation facilities, analytics including HPLC, GC, MS, Raman
spectroscopy as well as near- and mid-IR spectroscopy. A robotics suite is being
established with bespoke systems able to carry out automated gene assembly,
transformations, culturing and clone selection. The fermentation systems are of
particular note. A gas-fermentation laboratory was first established in 2013 to explore
anaerobic gas fermentation. Building on the knowledge gained from this facility, a new
laboratory suite dedicated to anaerobic and aerobic gas fermentation for the SBRC has
been commissioned and when fully operational will comprise over 20 gas-enabled
Controlled Stirred Tank Reactors (CSTRs) as well as a gas-enabled RoboLector®, bench
top micro fermentation system that allows high-throughput 48 X 2 ml fermentations
together with online monitoring. These facilities are amongst the few available in the UK
which have the capability to ferment waste C1 gases into fixed carbon from microbes.
Although the facility operates only at lab-scale the new knowledge being generated will
critically inform demonstrator and scale-up fermentation research. We are linking up
with the Centre for Process Innovation on Teesside, UK to establish best practice in gas
fermentation and gas safety in the UK and to share experience so that lab-scale
fermentation knowledge more readily integrates with scale-up to larger plant.
Training
The University has a BBSRC Doctoral Training Programme which annually recruits 50
students, or which a third are targeted for Industrial Biotechnology, an University funded
SBRC Synthetic Biology Doctoral Training Programme with 25 studentships to be
recruited over the 5-year funding lifetime of the SBRC and an EPSRC Doctoral Training
Centre in Sustainable Chemistry which will recruit 60 students over the same time
period. Together, these programmes are training the next generation of multi-
disciplinary scientists in Synthetic Biology and related areas of science.
Industrialisation and Application
SBRC-Nottingham is carrying out fundamental academic research to understand the
physiology and metabolism of microbial chassis that could have industrial application.
Key outputs of the centre are (i) knowledge of fermentation conditions and constraints
(ii) metabolic models which have through iteration led to (iii) optimised production
chassis. Many of these outputs will be of interest to industry either directly or to inform
industry’s processes which are developing in parallel. Translation to industry and the
wider academic community is further facilitated through the activities of the Nottingham
–led NIBB, C1net (www.c1net.co.uk).
Without compromising the SBRC-Nottingham’s academic interests and without
constraining the widespread distribution of project outputs, we have teamed up with a
newly formed synthetic biology company called CHAIN Biotechnology Ltd. This company
provides one of the routes we are using to facilitate the wider adoption and also the
exploitation of the outputs from the SBRC-Nottingham. This company has already taken
responsibility for the distribution of SBRC background IP. Through the University of
Nottingham, over 250 MTAs have been put in place for the pMTL80000 modular vector
series developed by the CRG [1]. CHAIN Biotechnology Ltd, will further expand the
distribution of these materials and build a global community of users to maximise the
wider impacts of SBRC-Nottingham research outputs. The pMTL80000 series is designed
for use in clostridial chassis. Further series are under development for Cupriavidus
(pMTL70000 series), Geobacillus (pMTL60000 series) and for methylotrophs (pMTL90000
series).
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